Summary
VBI Vaccines Inc (VBI), formerly SciVac Therapeutics Inc., discovers and develops novel vaccines for the treatment of infectious diseases and immuno-oncology. It offers Sci-B-Vac, a hepatitis B vaccine which mimics all the three viral surface antigens of hepatitis B virus. The company’s portfolio of pipeline vaccine candidates includes cytomegalovirus; glioblastoma multiforme and respiratory syncytial virus. VBI utilizes various technologies such as eVLP platform, thermostable platform and also ottawa research facility, scientific literature to develop the vaccine candidates. The company operates through its research facilities in Ottawa, Canada and a manufacturing facility in Rehovot, Israel. VBI is headquartered in Cambridge, Massachusetts, the US.
VBI Vaccines Inc (VBIV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
VBI Vaccines Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Variation Biotech Raises US$1.5 Million In Venture Financing 11
Variation Biotech Raised US$1.4 Million In Venture Financing 12
Variation Biotech Raises US$0.25 Million In Venture Financing 13
Variation Biotech Raises US$0.8 Million In Venture Financing 14
Variation Biotechnologies Raises US$1.2 Million In Venture Financing 15
Variation Biotech Raises Additional US$1.2 Million In Venture Financing 16
Variation Biotechnologies Raises US$2.2 Million In Venture Financing 17
Variation Biotechnologies Secures An Additional US$3.5 Million In Venture Financing 18
Partnerships 20
VBI Vaccines Enters into Research Agreement with GlaxoSmithKline Biologicals 20
VBI Vaccines Enters into Research Agreement with Sanofi Pasteur 21
Merger 22
Variation Biotechnologies Merges with Paulson Capital 22
Equity Offering 23
VBI Vaccines Raises USD10.6 Million in Private Placement of Shares and Warrants 23
VBI Vaccines Raises USD13.6 Million in Private Placement of Shares 24
VBI Vaccines Raises USD6.3 million in Private Placement Shares 26
Variation Biotechnologies Raises USD11 Million in Private Placement of Shares 27
Variation Biotechnologies Raises USD5.3 Million in Private Placement of Shares 28
Debt Offering 29
VBI Vaccines Raises USD13 Million in Debt Financing 29
Acquisition 30
SciVac Therapeutics Acquires VBI Vaccines 30
Levon Resources Acquires SciVac in Reverse Takeover Transaction 32
VBI Vaccines Acquires Epixis 34
VBI Vaccines Inc - Key Competitors 35
Key Employees 36
Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
List of Tables
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
VBI Vaccines Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
VBI Vaccines Inc, Deals By Therapy Area, 2010 to YTD 2016 8
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Variation Biotech Raises US$1.5 Million In Venture Financing 11
Variation Biotech Raised US$1.4 Million In Venture Financing 12
Variation Biotech Raises US$0.25 Million In Venture Financing 13
Variation Biotech Raises US$0.8 Million In Venture Financing 14
Variation Biotechnologies Raises US$1.2 Million In Venture Financing 15
Variation Biotech Raises Additional US$1.2 Million In Venture Financing 16
Variation Biotechnologies Raises US$2.2 Million In Venture Financing 17
Variation Biotechnologies Secures An Additional US$3.5 Million In Venture Financing 18
VBI Vaccines Enters into Research Agreement with GlaxoSmithKline Biologicals 20
VBI Vaccines Enters into Research Agreement with Sanofi Pasteur 21
Variation Biotechnologies Merges with Paulson Capital 22
VBI Vaccines Raises USD10.6 Million in Private Placement of Shares and Warrants 23
VBI Vaccines Raises USD13.6 Million in Private Placement of Shares 24
VBI Vaccines Raises USD6.3 million in Private Placement Shares 26
Variation Biotechnologies Raises USD11 Million in Private Placement of Shares 27
Variation Biotechnologies Raises USD5.3 Million in Private Placement of Shares 28
VBI Vaccines Raises USD13 Million in Debt Financing 29
SciVac Therapeutics Acquires VBI Vaccines 30
Levon Resources Acquires SciVac in Reverse Takeover Transaction 32
VBI Vaccines Acquires Epixis 34
VBI Vaccines Inc, Key Competitors 35
VBI Vaccines Inc, Key Employees 36
VBI Vaccines Inc, Other Locations 37
VBI Vaccines Inc, Subsidiaries 37
List of Figures
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
